Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review
Genes · 2024
DOI: 10.3390/genes15050553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von Niccolò Morisi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Surgical, Medical, Dental and Morphological Sciences Department (CHIMOMO), University of Modena and Reggio Emilia, 41124 Modena, Italy. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Cell-Free Nucleic Acids, DNA, Mitochondrial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Cell-free nucleic acids (cf-NAs) represent a promising biomarker of various pathological and physiological conditions. Since its discovery in 1948, cf-NAs gained prognostic value in oncology, immunology, and other relevant fields. In peritoneal dialysis (PD), blood purification is performed by exposing the peritoneal membrane. Relevant sections: Complications of PD such as acute peritonitis and peritoneal membrane aging are often critical in PD patient management. In this review, we focused on bacterial DNA, cell-free DNA, mitochondrial DNA (mtDNA), microRNA (miRNA), and their potential uses as biomarkers for monitoring PD and its complications. For instance, the isolation of bacterial DNA in early acute peritonitis allows bacterial identification and subsequent therapy implementation. Cell-free DNA in peritoneal dialysis effluent (PDE) represents a marker of stress of the peritoneal membrane in both acute and chronic PD complications. Moreover, miRNA are promising hallmarks of peritoneal membrane remodeling and aging, even before its manifestation. In this scenario, with multiple cytokines involved, mtDNA could be considered equally meaningful to determine tissue inflammation.
Conclusions
This review explores the relevance of cf-NAs in PD, demonstrating its promising role for both diagnosis and treatment. Further studies are necessary to implement the use of cf-NAs in PD clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Surgical, Medical, Dental and Morphological Sciences Department (CHIMOMO), University of Modena and Reggio Emilia, 41124 Modena, Italy.
- Department of Nephrology, Dialysis and Transplant, St. Bortolo Hospital, 36100 Vicenza, Italy.
- IRRIV-International Renal Research Institute Vicenza-Foundation, 36100 Vicenza, Italy.
- Nephrology Dialysis and Transplant Unit, University Hospital of Modena, 41124 Modena, Italy.
ORCID-Profile: Niccolò Morisi, Grazia Maria Virzì, Gaetano Alfano, Gabriele Donati
Zitieren
APA
Morisi, N., Virzì, G. M., Ferrarini, M., Alfano, G., Zanella, M., Ronco, C., & Donati, G. (2024). Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review. Genes. https://doi.org/10.3390/genes15050553
Vancouver
Morisi N, Virzì GM, Ferrarini M, Alfano G, Zanella M, Ronco C, et al. Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review. Genes. 2024. doi:10.3390/genes15050553
BibTeX
@article{Morisi2024,
author = {Morisi, Niccolò and Virzì, Grazia Maria and Ferrarini, Marco and Alfano, Gaetano and Zanella, Monica and Ronco, Claudio and Donati, Gabriele},
title = {Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15050553}
}
EUVIMED